Adaptive Biotechnologies (ADPT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
ADPTAdaptive Biotechnologies(ADPT) ZACKS·2024-08-02 08:00

For the quarter ended June 2024, Adaptive Biotechnologies (ADPT) reported revenue of 43.19million,down11.743.19 million, down 11.7% over the same period last year. EPS came in at -0.26, compared to -0.33intheyear−agoquarter.ThereportedrevenuecomparestotheZacksConsensusEstimateof0.33 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of 38.52 million, representing a surprise of +12.13%. The company delivered an EPS surprise of +18.75%, with the consensus EPS estimate being -$0.32.While investors closely watch year-over-year changes in headline numbers -- revenue and ea ...